Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Thorax. 2016 Nov 15;72(4):318–326. doi: 10.1136/thoraxjnl-2016-208949

Figure 2. (A Rx and B Obs-arm) Participant-specific MRSA culture results through Day 168 by treatment arm.

Figure 2

Figure 2

Individual participant MRSA culture status across time is shown. History of MRSA positive isolate is also shown. Participants with who are P. aeruginosa positive (Pa +) are indicated by □. Acute events treated with anti-MRSA active antibiotics are marked with an ‘X’. The locations of the ‘X’s indicate the timing of the antibiotic course in relationship to the study visits but do not represent an actual day as measured from screening. Participants enrolled prior to protocol amendment are marked with an asterisk (see Discussion).